<form id="r913x"><form id="r913x"></form></form>

        <em id="r913x"></em>

        <em id="r913x"><form id="r913x"></form></em>

          Products and services

          Products and services

          Donepezil Hydrochloride Tablets

          適  應  癥:For the treatment of minor, moderate or severe symptoms of Alzheimer’s disease.

          規       格:5mg, 10mg

          包       裝:cellophane/aluminum/polyethylene pharmaceutical laminate film package, 7 tablets/blister x 1 blister/carton, 7 tablets/blister x 2 blisters/carton

          有  效  期:24 months

          批準文號:5mg: National Medicine Standard H20010723
                           10mg: National Medicine Standard H20204034

          - First in the country to pass the consistency evaluation of generic drugs.

          - This product is the first drug approved by the FDA for the treatment of minor to severe Alzheimer's disease.

          - It is a highly selective, reversible, long-acting cholinesterase inhibitor.

          - A large amount of evidence-based proof shows that donepezil can improve patients' cognitive ability and memory impairment

          - Minor adverse reaction, better safety.

          - Once daily, easy to dose.

          -  Firstly launched in China market.